reverse transcriptase m-mul v

 Product Description

biotechrabbit MMuLV Reverse Transcriptase is an exceptionally pure DNA polymerase which uses RNA as a substrate and exhibits no measurable proofreading 3’→5′ exonuclease function. This enzyme performs cDNA synthesis by extending a DNA primer annealed to an RNA template; it can also make copies from a single-stranded DNA templates.

The enzyme is purified from a recombinant E. coli strain carrying the MMuLV reverse transcriptase gene.

 

 

Component	Composition
MMuLV Reverse Transcriptase	MMuLV Reverse Transcriptase, 200 U/µl, in storage buffer containing 50% (v/v) glycerol.
10× MMuLV RT Buffer	Optimized 10× MMuLV Reverse Transcriptase reaction buffer.

 

STORAGE

-20°C (until expiry date – see product label)

Unit Definition

One unit is the amount of enzyme activity that incorporates 1 nmole of dTTP into acid insoluble fraction in 10 minutes at 42°C when poly(A)+ RNA and oligo (dT)20 are used as template-primer.

Quality Control

Functional Assay

cDNA synthesis with specific primers, followed by quantitative PCR.

Exonuclease assay

Linearized lambda/HindII fragments are incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.

Endonuclease assay

lambda DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.

Nick Activity

Supercoiled plasmid DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No conversion of covalently closed circular DNA to nicked DNA was detected.

E. coli genomic DNA contamination assay

A sample of Reverse Transcriptase is analyzed with specific primers targeting the 16S rRNA gene in qPCR for the presence of contaminating E. coli DNA. No E. coli DNA was detectable.

RNase Assay

A sample of the enzyme was incubated with a RNA template. RNase activity was not observed after agarose gel electrophoresis.

 

Prevention of cDNA synthesis reaction contamination

RNase contamination is an exceptional concern when working with RNA. RNase A, providing most threat to RNA integrity, is a highly stable contaminant of any laboratory. To prevent RNA from degradation and to minimize possibility of contamination during cDNA synthesis; follow the guidelines below:

• Use separate clean areas for preparation of the samples and the reaction mixture.
• DEPC-treat all tubes and pipette tips or use certified nuclease-free labware with aerosol filters.
• Wear fresh gloves when handling RNA and all reagents.
• Always assess the integrity of RNA prior to cDNA synthesis in denaturing agarose gel electrophoresis.
• Use RNase free water and other reagents.
• To prevent RNA from degradation, add Ribonuclease inhibitor (optional) in to the cDNA synthesis reaction (20 units for 20 µl reaction).

Typical cDNA synthesis reaction set up

• Thaw on ice and mix very well all reagents.
• Assemble and keep all reactions on ice.
• To use time and reagents effectively, always prepare master mix for multiple reactions. For a master mix volume, always calculate the number reactions that you need plus one additional.
• Combine the following in an RNase-free reaction tube:

Component	Volume	Final concentration
dNTP Mix (10 mM each dNTP)	4 µl	2 mM (each dNTP)
RNase Inhibitor, 40 U/µl (optional)	1 µl	2 U/µl
Oligo (dT)12–18 (10 µM) – or Hexamer Primer (25 µM) – or Gene Specific Primer (10 µM)	0.5 µl 1 µl 0.5 µl	0.25 µM 1.25 µM 0.25 µM
10× MMuLV RT Buffer	2 µl	1×
RNA Template	0.5–5 µg total RNA or 50–500 ng mRNA (polyA)
MMuLV Reverse Transcriptase	1 µl	10 U/µl
RNase-free water	Variable
Total volume	20 µl

• Mix and collect the drops by centrifuging briefly.
• When using
  • Hexamer Primer, incubate 10 minutes at 25°C followed by 42°C for 45–60 minutes
  • Oligo (dT) or gene-specific Primer incubate at 42°C for 45–60 minutes.
• Inactivate enzyme at 85°C for 10 minutes.
• Collect the drops by spinning briefly.
• Store products at –20°C or proceed to next step, like PCR or qPCR.
• Use maximum 10 µl of the cDNA synthesis reaction mix for PCR in 50 µl volume.

 

IL-6 Neutralizing Antibody
MBS8102624-5x05mg	MyBiosource	5x0.5mg	EUR 1545

Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay)
BCA-M43	ACROBIOSYSTEMS	100ug	EUR 2398
Description: Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) is also known as B-cell maturation protein (BCMA), CD antigen CD269, which is a member of the TNF-receptor superfamily. TNFRSF17 contains one TNFR-Cys repeat. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. TNFRSF17 is receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B-cell survival and plays a role in the regulation of humoral immunity. TNFRSF17 can activate NF-kappa-B and JNK.

DKK-1 Neutralizing Antibody
MBS8101470-02mg	MyBiosource	0.2mg	EUR 280

DKK-1 Neutralizing Antibody
MBS8101470-05mg	MyBiosource	0.5mg	EUR 375

DKK-1 Neutralizing Antibody
MBS8101470-5x05mg	MyBiosource	5x0.5mg	EUR 1545

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)
abx411284-01mg	Abbexa	0.1 mg	EUR 610.8

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)
abx411284-100g	Abbexa	100 µg	EUR 425

NGF/NGFB Neutralizing Antibody
MBS8104707-02mg	MyBiosource	0.2mg	EUR 280

NGF/NGFB Neutralizing Antibody
MBS8104707-05mg	MyBiosource	0.5mg	EUR 375

NGF/NGFB Neutralizing Antibody
MBS8104707-5x05mg	MyBiosource	5x0.5mg	EUR 1545

NGF/NGFB Neutralizing Antibody
MBS8104710-02mg	MyBiosource	0.2mg	EUR 280

NGF/NGFB Neutralizing Antibody
MBS8104710-05mg	MyBiosource	0.5mg	EUR 375

NGF/NGFB Neutralizing Antibody
MBS8104710-5x05mg	MyBiosource	5x0.5mg	EUR 1545

IL17/IL17a Neutralizing Antibody
MBS8106122-02mg	MyBiosource	0.2mg	EUR 280

IL17/IL17a Neutralizing Antibody
MBS8106122-05mg	MyBiosource	0.5mg	EUR 375

IL17/IL17a Neutralizing Antibody
MBS8106122-5x05mg	MyBiosource	5x0.5mg	EUR 1545

HER3/ErbB3 Neutralizing Antibody
MBS8101672-02mg	MyBiosource	0.2mg	EUR 280

HER3/ErbB3 Neutralizing Antibody
MBS8101672-05mg	MyBiosource	0.5mg	EUR 375

HER3/ErbB3 Neutralizing Antibody
MBS8101672-5x05mg	MyBiosource	5x0.5mg	EUR 1545

HER3/ErbB3 Neutralizing Antibody
MBS8101673-02mg	MyBiosource	0.2mg	EUR 280

HER3/ErbB3 Neutralizing Antibody
MBS8101673-05mg	MyBiosource	0.5mg	EUR 375

HER3/ErbB3 Neutralizing Antibody
MBS8101673-5x05mg	MyBiosource	5x0.5mg	EUR 1545

HER3/ErbB3 Neutralizing Antibody
MBS8101674-02mg	MyBiosource	0.2mg	EUR 280

HER3/ErbB3 Neutralizing Antibody
MBS8101674-05mg	MyBiosource	0.5mg	EUR 375

HER3/ErbB3 Neutralizing Antibody
MBS8101674-5x05mg	MyBiosource	5x0.5mg	EUR 1545

HER3/ErbB3 Neutralizing Antibody
MBS8101675-02mg	MyBiosource	0.2mg	EUR 280

HER3/ErbB3 Neutralizing Antibody
MBS8101675-05mg	MyBiosource	0.5mg	EUR 375

HER3/ErbB3 Neutralizing Antibody
MBS8101675-5x05mg	MyBiosource	5x0.5mg	EUR 1545

Anti-BTLA Neutralizing Antibody
100244	BPS Bioscience	100 µg	EUR 355
Description: This anti-BTLA antibody is a purified recombinant human monoclonal antibody which recognizes the human BTLA protein. BTLA (B- and T-lymphocyte attenuator) belongs to the CD28 immunoglobulin superfamily (IgSF) and is an immune-regulatory receptor that binds to HVEM (Herpesvirus entry mediator, also known as TNFRSF14, Tumor necrosis factor receptor superfamily member 14). This antibody has been tested for specific binding to purified human BTLA protein and neutralizes the interaction between BTLA and HVEM.

Anti-VEGF Neutralizing Antibody
79478-1	BPS Bioscience	50 µg	EUR 355
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.

Anti-VEGF Neutralizing Antibody
79478-2	BPS Bioscience	100 g	EUR 460
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.